SERUM BILE ACID KINETICS & REGULATION OF BIOSYNTHESIS
SERUM BILE ACID KINETICS & REGULATION OF BIOSYNTHESIS
批准号:
3078998
负责人:
Gregory Thomas Everson
金额:
$7.44万
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-04-01 至 1986-03-31
中文摘要
这项建议的目的是调查负责的机制,
观察到血清和
胆汁,以验证使用两种稳定同位素的单样本血清技术
用于胆汁酸动力学的测量,以研究
妊娠和口服避孕激素对胆汁酸转化的影响
中间体,7 α-羟基-4-异戊烯-3-酮,转化为鹅去氧胆酸
(CDCA)和胆酸(CA),并直接测量胆汁酸合成
使用18 O吸入技术。 以下所有实验将
使用气相色谱/质谱/稳定同位素进行
比率测定法 胆汁和血清胆汁酸动力学将进行比较,
胆囊受试者和5例胆囊切除术后受试者使用
13 C-24-CDCA和13 C-24-CA。 在10例受试者中,我们将比较血清胆汁酸
通过双同位素稀释从一份血清样品获得动力学
与使用多样本血清技术的那些技术。 在5
孕妇和5名妇女服用避孕类固醇,我们将研究
关键胆汁酸中间体的转化,
7 α-羟基-4-异戊烯-3-酮(HCO)转化为CDCA和CA,使用氘代HCO
以及13 C-24-CDCA和13-24-CA。 代谢为CDCA的HCO分数,
将CA与CDCA和CA的生产率进行比较。 我们将
直接测量5名健康受试者的胆汁酸合成,
通过测量180掺入胆汁酸的考来烯胺
在吸入富含180的大气后, 这些
研究将解释我们观察到的池大小之间的差异
从血清和胆汁中测量。 它们将极大地扩展我们的能力,
由于受试者依从性改善,
质谱实验室的分析时间。 HCO研究可
指出胆汁酸生物合成的途径,是由女性改变
类固醇激素,从而提供有关
雌性类固醇激素作用的细胞内定位。 这
信息将有助于了解发病机制的增加
女性患胆固醇结石的风险,尤其是那些暴露于高胆固醇的女性。
女性类固醇激素的浓度。 180研究将验证
用于随后测量女性的短期效应的技术
类固醇激素对胆汁酸合成的影响。
英文摘要
The aims of this proposal are to investigate the mechanism responsible for
observed differences in bile acid pool size measurements between serum and
bile, to validate a single sample serum technique using two stable isotopes
for measurement of bile acid kinetics, to investigate the effects of
pregnancy and oral contraceptive steroids on conversion of the bile acid
intermediate, 7 Alpha-hydroxy-4-cholesten-3-one, to chenodeoxycholic acid
(CDCA) and cholic acid (CA) and to directly measure bile acid synthesis
using an 18O inhalation technique. All of the following experiments will
be performed using gas chromatography/mass spectromatry/stable isotope
ratiometry. Biliary and serum bile acid kinetics will be compared in 5
subjects with gallbladders and 5 subjects post-cholecystectomy using
13C-24-CDCA and 13C-24-CA. In 10 subjects we will compare serum bile acid
kinetics obtained from one serum sample by double isotope dilution
technique with those using the multiple sample serum technique. In 5
pregnant women and 5 women taking contraceptive steroids we will study the
conversion of a key bile acid intermediate,
7Alpha-hydroxy-4-cholesten-3-one (HCO) to CDCA and CA, using deuterated HCO
and 13C-24-CDCA, and 13-24-CA. The fraction of HCO metabolized to CDCA AND
CA will be compared to the production rates of CDCA and CA. We will
directly measure bile acid synthesis in 5 healthy subjects on and off
cholestyramine by measuring the incorporation of 180 into bile acid
hydroxyl groups after inhalation of an 180 enriched atmosphere. These
studies will explain the difference we have observed between pool size
measured from serum and bile. They will greatly expand our ability to do
ble acid kinetics because of improved subject compliance and decreased
analytical time in the mass spectrometry laboratory. The HCO study may
pinpoint the pathway of bile acid biosynthesis that is altered by female
steroid hormones and thereby provide indirect information about the
intracellular localization of action of female steroid hormones. This
information will aid in understanding the pathogenesis of the increased
risk of cholesterol gallstones in women especially those exposed to high
concentrations of female steroid hormones. The 180 study will validate a
technique for subsequent measurement of the short-term effect of female
steroid hormones on bile acid synthesis.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
--
发表时间:
1987-03
期刊:
Journal of lipid research
影响因子:
6.5
作者:
[G. Everson]
通讯作者:
G. Everson
Hepatocyte-hepatoma cell hybrids. Characterization and demonstration of bile acid synthesis.
肝细胞-肝癌细胞杂交体。
DOI:
--
发表时间:
1986
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[Polokoff,MA, Everson,GT]
通讯作者:
Everson,GT
HepG2. A human hepatoblastoma cell line exhibiting defects in bile acid synthesis and conjugation.
HepG2。
DOI:
--
发表时间:
1986
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[Everson,GT, Polokoff,MA]
通讯作者:
Polokoff,MA
Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL)
-
批准号:8015117
-
项目类别:
-
资助金额:$3.06万
-
财政年份:2010
-
负责人:Gregory Thomas Everson
-
依托单位:
A2ALL LADR PROTOCOL:PRE-TRNSPLNT TRTMNT TO PRVNT RCURRNCE OF HEPC AFT LVR TRNSPL
-
批准号:7719478
-
项目类别:
-
资助金额:$0.09万
-
财政年份:2008
-
负责人:Gregory Thomas Everson
-
依托单位:
QUANTITATIVE ASSESSMENT OF HEPATIC FUNCTION IN CHRONIC HCV (QLFT)
-
批准号:7719422
-
项目类别:
-
资助金额:$0.15万
-
财政年份:2008
-
负责人:Gregory Thomas Everson
-
依托单位:
HEPATITIS C ANTIVIRAL LONG-TERM TREATMENT TO PREVENT CIRRHOSIS (HALT-C)
-
批准号:7719421
-
项目类别:
-
资助金额:$1.78万
-
财政年份:2008
-
负责人:Gregory Thomas Everson
-
依托单位:
RESTORATION OF HEPATIC FUNCTION IN LIVING LIVER DONORS (ANCILLARY STUDY OF A2ALL
-
批准号:7719472
-
项目类别:
-
资助金额:$0.05万
-
财政年份:2008
-
负责人:Gregory Thomas Everson
-
依托单位:
QUANTITATIVE ASSESSMENT OF HEPATIC FUNCTION IN CHRONIC HCV (QLFT)
-
批准号:7604372
-
项目类别:
-
资助金额:$1.31万
-
财政年份:2007
-
负责人:Gregory Thomas Everson
-
依托单位:
RESTORATION OF HEPATIC FUNCTION IN LIVING LIVER DONORS (ANCILLARY STUDY OF A2ALL
-
批准号:7604422
-
项目类别:
-
资助金额:$0.4万
-
财政年份:2007
-
负责人:Gregory Thomas Everson
-
依托单位:
A2ALL LADR PROTOCOL:PRE-TRNSPLNT TRTMNT TO PRVNT RCURRNCE OF HEPC AFT LVR TRNSPL
-
批准号:7604428
-
项目类别:
-
资助金额:$0.81万
-
财政年份:2007
-
负责人:Gregory Thomas Everson
-
依托单位:
HEPATITIS C ANTIVIRAL LONG-TERM TREATMENT TO PREVENT CIRRHOSIS (HALT-C)
-
批准号:7604371
-
项目类别:
-
资助金额:$15.15万
-
财政年份:2007
-
负责人:Gregory Thomas Everson
-
依托单位:
A2ALL LADR PROTOCOL:PRE-TRNSPLNT TRTMNT TO PRVNT RCURRNCE OF HEPC AFT LVR TRNSPL
-
批准号:7377842
-
项目类别:
-
资助金额:$0.34万
-
财政年份:2006
-
负责人:Gregory Thomas Everson
-
依托单位:
HEPATITIS C ANTIVIRAL LONG-TERM TREATMENT TO PREVENT CIRRHOSIS (HALT-C)
-
批准号:7377765
-
项目类别:
-
资助金额:$15.78万
-
财政年份:2006
-
负责人:Gregory Thomas Everson
-
依托单位:
QUANTITATIVE ASSESSMENT OF HEPATIC FUNCTION IN CHRONIC HCV (QLFT)
-
批准号:7377766
-
项目类别:
-
资助金额:$0.68万
-
财政年份:2006
-
负责人:Gregory Thomas Everson
-
依托单位:
HEPATITIS C ANTIVIRAL LONG-TERM TREATMENT TO PREVENT CIRRHOSIS (HALT-C)
-
批准号:7200525
-
项目类别:
-
资助金额:$18.64万
-
财政年份:2005
-
负责人:Gregory Thomas Everson
-
依托单位:
QUANTITATIVE ASSESSMENT OF HEPATIC FUNCTION IN CHRONIC HCV (QLFT)
-
批准号:7200526
-
项目类别:
-
资助金额:$3.86万
-
财政年份:2005
-
负责人:Gregory Thomas Everson
-
依托单位:
Quantitative Assessment of Hepatic Function
-
批准号:6982140
-
项目类别:
-
资助金额:$1.7万
-
财政年份:2004
-
负责人:Gregory Thomas Everson
-
依托单位:
Hepatitis C Antiviral Treatment to Prevent Cirrhosis
-
批准号:6982139
-
项目类别:
-
资助金额:$22.2万
-
财政年份:2004
-
负责人:Gregory Thomas Everson
-
依托单位:
Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL)
-
批准号:7791894
-
项目类别:
-
资助金额:$21.71万
-
财政年份:2002
-
负责人:Gregory Thomas Everson
-
依托单位:
Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL)
-
批准号:8131408
-
项目类别:
-
资助金额:$3.35万
-
财政年份:2002
-
负责人:Gregory Thomas Everson
-
依托单位:
Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL)
-
批准号:8145314
-
项目类别:
-
资助金额:$17.23万
-
财政年份:2002
-
负责人:Gregory Thomas Everson
-
依托单位:
Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL)
-
批准号:7938059
-
项目类别:
-
资助金额:$22.64万
-
财政年份:2002
-
负责人:Gregory Thomas Everson
-
依托单位:
海外基金